{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:43:37Z","timestamp":1776732217554,"version":"3.51.2"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T00:00:00Z","timestamp":1377561600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Wolfram, Alstr\u00f6m and Bardet-Biedl (WABB) syndromes are rare diseases with overlapping features of multiple sensory and metabolic impairments, including diabetes mellitus, which have caused diagnostic confusion. There are as yet no specific treatments available, little or no access to well characterized cohorts of patients, and limited information on the natural history of the diseases. We aim to establish a Europe-wide registry for these diseases to inform patient care and research.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>EURO-WABB is an international multicenter large-scale observational study capturing longitudinal clinical and outcome data for patients with WABB diagnoses. Three hundred participants will be recruited over 3\u00a0years from different sites throughout Europe. Comprehensive clinical, genetic and patient experience data will be collated into an anonymized disease registry. Data collection will be web-based, and forms part of the project\u2019s Virtual Research and Information Environment (VRIE). Participants who haven\u2019t undergone genetic diagnostic testing for their condition will be able to do so via the project.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The registry data will be used to increase the understanding of the natural history of WABB diseases, to serve as an evidence base for clinical management, and to aid the identification of opportunities for intervention to stop or delay the progress of the disease. The detailed clinical characterisation will allow inclusion of patients into studies of novel treatment interventions, including targeted interventions in small scale open label studies; and enrolment into multi-national clinical trials. The registry will also support wider access to genetic testing, and encourage international collaborations for patient benefit.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2431-13-130","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T00:15:02Z","timestamp":1377648902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["EURO-WABB: an EU rare diseases registry for Wolfram syndrome, Alstr\u00f6m syndrome and Bardet-Biedl syndrome"],"prefix":"10.1186","volume":"13","author":[{"given":"Amy","family":"Farmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9gol\u00e8ne","family":"Aym\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Lopez","family":"de Heredia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Maffei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"McCafferty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"M\u0142ynarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay","family":"Parkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Paquis-Flucklinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Rohayem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Sinnott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vallo","family":"Tillmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisbeth","family":"Tranebj\u00e6rg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy G","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,27]]},"reference":[{"key":"861_CR1","unstructured":"Orphanet Report Series, Rare Diseases collection, June 2013, Number 1: Listed in alphabetical order of disease or group of diseases. Prevalence of rare diseases: Bibliographic data. 2013, http:\/\/www.orpha.net\/orphacom\/cahiers\/docs\/GB\/Prevalence_of_rare_diseases_by_alphabetical_list.pdf,"},{"key":"861_CR2","unstructured":"Regulation (EC) No 141\/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. Official Journal of the European Communities. 2000, L18: 1-5. http:\/\/ec.europa.eu\/health\/files\/eudralex\/vol-1\/reg_2000_141\/reg_2000_141_en.pdf,"},{"key":"861_CR3","unstructured":"Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions: On Rare Diseases: Europe\u2019s challenges. Commission of the European Communities, http:\/\/ec.europa.eu\/health\/ph_threats\/non_com\/docs\/rare_com_en.pdf,"},{"key":"861_CR4","first-page":"7","volume":"C151","author":"European Union","year":"2009","unstructured":"European Union: Council Recommendation of 8 June 2009 on an action in the field of rare diseases. Official J European Union. 2009, C151: 7-10.","journal-title":"Official J European Union"},{"key":"861_CR5","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/S0140-6736(95)92473-6","volume":"346","author":"TG Barrett","year":"1995","unstructured":"Barrett TG, Bundey SE, Macleod AF: Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet. 1995, 346: 1458-1463. 10.1016\/S0140-6736(95)92473-6.","journal-title":"Lancet"},{"key":"861_CR6","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/jmg.34.10.838","volume":"34","author":"TG Barrett","year":"1997","unstructured":"Barrett TG, Bundey SE: Wolfram (DIDMOAD) syndrome. J Med Genet. 1997, 34: 838-841. 10.1136\/jmg.34.10.838.","journal-title":"J Med Genet"},{"key":"861_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00401-009-0546-8","volume":"118","author":"JB Hilson","year":"2009","unstructured":"Hilson JB, Merchant SN, Adams JC, Joseph JT: Wolfram syndrome: a clinicopathologtr,ic correlation. Acta Neuropathol. 2009, 118: 415-428. 10.1007\/s00401-009-0546-8.","journal-title":"Acta Neuropathol"},{"key":"861_CR8","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1212\/WNL.42.6.1220","volume":"42","author":"TA Rando","year":"1992","unstructured":"Rando TA, Horton JC, Layzer RC: Wolfram syndrome: evidence of a diffuse neurodegenerative disease by magnetic resonance imaging. Neurology. 1992, 42: 1220-1224. 10.1212\/WNL.42.6.1220.","journal-title":"Neurology"},{"key":"861_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ng0994-95","volume":"8","author":"MH Polymeropoulos","year":"1994","unstructured":"Polymeropoulos MH, Swift RG, Swift M: Linkage of the gene for Wolfram syndrome to markers on the short arm of chromosome 4. Nat Genet. 1994, 8: 95-97. 10.1038\/ng0994-95.","journal-title":"Nat Genet"},{"key":"861_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/2441","volume":"20","author":"H Inoue","year":"1998","unstructured":"Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, Bernal-Mizrachi E, Mueckler M, Marshall H, Donis-Keller H, Crock P, Rogers D, Mikuni M, Kumashiro H, Higashi K, Sobue G, Oka Y, Permutt MA: A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet. 1998, 20: 143-148. 10.1038\/2441.","journal-title":"Nat Genet"},{"key":"861_CR11","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/hmg\/7.13.2021","volume":"7","author":"TM Strom","year":"1998","unstructured":"Strom TM, Hortnagel K, Hofmann S, Gekeler F, Scharfe C, Rabl W, Gerbitz KD, Meitinger T: Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet. 1998, 7: 2021-2028. 10.1093\/hmg\/7.13.2021.","journal-title":"Hum Mol Genet"},{"key":"861_CR12","first-page":"1997","volume-title":"WFS1-related disorders, Gene reviews at genetests: medical genetics information resource [database online]","author":"L Tranebjaerg","year":"2009","unstructured":"Tranebjaerg L, Barrett T, Rendtorff ND: WFS1-related disorders, Gene reviews at genetests: medical genetics information resource [database online]. 2009, Seattle: University of Washington, 1997-2008."},{"issue":"suppl. 129","key":"861_CR13","first-page":"1","volume":"34","author":"C Alstr\u00f6m","year":"1959","unstructured":"Alstr\u00f6m C, Hallgren B, Nilsson LB, \u00c5sander A: Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome (not hitherto described) distinct from Laurence-Moon-Biedl syndrome a clinical endocrinological and genetic examination based on a large pedigree. Acta Psychiatr Neurol Scand. 1959, 34 (suppl. 129): 1-35.","journal-title":"Acta Psychiatr Neurol Scand"},{"issue":"4","key":"861_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/MOL.0b013e32832dd51a","volume":"20","author":"R Paisey","year":"2009","unstructured":"Paisey R: New insights and therapies for the metabolic consequences of Alstr\u00f6m syndrome. Curr Opin Lipidol. 2009, 20 (4): 315-320. 10.1097\/MOL.0b013e32832dd51a.","journal-title":"Curr Opin Lipidol"},{"key":"861_CR15","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/S0161-6420(98)97033-6","volume":"105","author":"I Russell-Eggitt","year":"1998","unstructured":"Russell-Eggitt I, Clayton P, Coffey R, Kriss A, Taylor D, Taylor J: Alstr\u00f6m syndrome: report of 22 cases and literature review. Ophthalmology. 1998, 105: 1274-128. 10.1016\/S0161-6420(98)97033-6.","journal-title":"Ophthalmology"},{"key":"861_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1750-1172-4-14","volume":"4","author":"M Loudon","year":"2009","unstructured":"Loudon M, Bellenger N, Carey C, Paisey R: Cardiac magnetic resonance imaging in Alstr\u00f6m syndrome. Orphanet J Rare Dis. 2009, 4: 14-10.1186\/1750-1172-4-14.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"861_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/MAJ.0b013e3181926594","volume":"337","author":"EY Khoo","year":"2009","unstructured":"Khoo EY, Risley J, Zaitoun AM, El-Sheikh M, Paisey RB, Acheson AG, Mansell P: Alstr\u00f6m syndrome and cecal volvulus in 2 siblings. Am J Med Sci. 2009, 337 (5): 383-385. 10.1097\/MAJ.0b013e3181926594.","journal-title":"Am J Med Sci"},{"issue":"6","key":"861_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/archinte.165.6.675","volume":"165","author":"J Marshall","year":"2005","unstructured":"Marshall J, Bronson R, Collin G, Nordstrom A, Maffei P, Paisey R, Carey C, Macdermott S, Russell-Eggitt I, Shea S, Davis J, Beck S, Shatirishvili G, Mihai C, Hoeltzenbein M, Pozzan G, Hopkinson I, Sicolo N, Naggert J, Nishina P: New Alstr\u00f6m syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med. 2005, 165 (6): 675-683. 10.1001\/archinte.165.6.675.","journal-title":"Arch Intern Med"},{"issue":"2","key":"861_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1365-2265.2004.01952.x","volume":"60","author":"RB Paisey","year":"2004","unstructured":"Paisey RB, Carey CM, Bower L, Marshall J, Taylor P, Maffei P, Mansell P: Hypertriglyceridaemia in Alstr\u00f6m\u2019s syndrome: causes and associations in 37 cases. Clin Endocrinol (Oxf). 2004, 60 (2): 228-231. 10.1111\/j.1365-2265.2004.01952.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"861_CR20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ng874","volume":"31","author":"T Hearn","year":"2002","unstructured":"Hearn T, Renforth G, Spalluto C, Hanley N, Piper K, Brickwood S, White C, Connolly V, Taylor J, Russell-Eggitt I, Bonneau D, Walker M, Wilson D: Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alstr\u00f6m syndrome. Nat Genet. 2002, 31 (1): 79-83.","journal-title":"Nat Genet"},{"key":"861_CR21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ng867","volume":"31","author":"GB Collin","year":"2002","unstructured":"Collin GB, Marshall JD, Ikeda A, Venus So W, Russell-Eggitt I, Maffei P, Beck S, Boerkoel CF, Sicolo N, Martin M, Nishina PM, Naggert JK: Mutations in ALMS1 cause obesity, type 2 diabetes andneurosensory degeneration in Alstr\u00f6m syndrome. Nat Genet. 2002, 31: 74-78.","journal-title":"Nat Genet"},{"issue":"3","key":"861_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2174\/138920211795677912","volume":"12","author":"JD Marshall","year":"2011","unstructured":"Marshall JD, Maffei P, Collin GB, Naggert JK: Alstr\u00f6m syndrome: genetics and clinical overview. Curr Genomics. 2011, 12 (3): 225-235. 10.2174\/138920211795677912.","journal-title":"Curr Genomics"},{"issue":"6","key":"861_CR23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/jmg.36.6.437","volume":"36","author":"PL Beales","year":"1999","unstructured":"Beales PL, Elcioglu N, Woolf AS, Parker D, Flinter FA: New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J Med Genet. 1999, 36 (6): 437-446.","journal-title":"J Med Genet"},{"issue":"8","key":"861_CR24","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/jmedgenet-2012-100875","volume":"49","author":"C Redin","year":"2012","unstructured":"Redin C, Le Gras S, Mhamdi O, Geoffroy V, Stoetzel C, Vincent MC, Chiurazzi P, Lacombe D, Ouertani I, Petit F, Till M, Verloes A, Jost B, Chaabouni HB, Dollfus H, Mandel JL, Muller J: Targeted high-throughput sequencing for diagnosis of genetically heterogeneous diseases: efficient mutation detection in Bardet-Biedl and Alstr\u00f6m syndromes. J Med Genet. 2012, 49 (8): 502-512. 10.1136\/jmedgenet-2012-100875.","journal-title":"J Med Genet"},{"issue":"3","key":"861_CR25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/10372","volume":"22","author":"V Labay","year":"1999","unstructured":"Labay V, Raz T, Baron D, Mandel H, Williams H, Barrett T, Szargel R, McDonald L, Shalata A, Nosaka K, Gregory S, Cohen N: Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat Genet. 1999, 22 (3): 300-304. 10.1038\/10372.","journal-title":"Nat Genet"},{"key":"861_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/78085","volume":"25","author":"M Delepine","year":"2000","unstructured":"Delepine M, Nicolino M, Barrett T, Golomaully M, Lathrop G, Julier C: E1F2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet. 2000, 25: 406-409. 10.1038\/78085.","journal-title":"Nat Genet"},{"issue":"5","key":"861_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/humu.21438","volume":"35","author":"I Fokkema","year":"2011","unstructured":"Fokkema I, Taschner P, Schaafsma G, Celli J, Laros J, Dunnen J: LOVD v2.0: The Next Generation in Gene Variant Databases. Hum Mutat. 2011, 35 (5): 557-563. 10.1002\/humu.21438.","journal-title":"Hum Mutat"},{"issue":"Supp 2","key":"861_CR28","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1038\/sj.ejhg.5201111","volume":"11","author":"B Godard","year":"2003","unstructured":"Godard B, Kaariainen H, Kristoffersson U, Tranebjaerg L, Coviello D, Aym\u00e9 S: Provision of genetic services in Europe: current practices and issues. Eur J Hum Genet. 2003, 11 (Supp 2): S13-S48.","journal-title":"Eur J Hum Genet"},{"key":"861_CR29","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/sj.ejhg.5201103","volume":"11","author":"S Aym\u00e9","year":"2003","unstructured":"Aym\u00e9 S: Provision of genetic services in Europe: current practices and issues. Eur J Hum Genet. 2003, 11: 900-902.","journal-title":"Eur J Hum Genet"},{"key":"861_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","volume":"30","author":"CM Eng","year":"2007","unstructured":"Eng CM, Fletcher J, Wilcox WR, Waldek S, Scott CR, Sillence DO, Breunig F, Charrow J, Germain DP, Nicholls K, Banikazemi M: Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. J Inherit Metab Dis. 2007, 30: 184-192. 10.1007\/s10545-007-0521-2.","journal-title":"J Inherit Metab Dis"},{"key":"861_CR31","volume-title":"RDTF Report on Patient registries the field of rare diseases: Overview of the issues surrounding the establishment, governance and financing of academic registries","author":"S Aym\u00e9","year":"2011","unstructured":"Aym\u00e9 S, Kole A, Rodwell C: RDTF Report on Patient registries the field of rare diseases: Overview of the issues surrounding the establishment, governance and financing of academic registries. 2011, http:\/\/nestor.orpha.net\/EUCERD\/upload\/file\/RDTFRegistriesrev2011.pdf,"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-13-130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2431-13-130\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-13-130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-13-130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T04:16:22Z","timestamp":1688444182000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/1471-2431-13-130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,27]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1186\/1471-2431-13-130","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,27]]},"assertion":[{"value":"31 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"130"}}